TD2

Therapeutic Discovery and Development (TD2) is an oncology-focused contract research organization (CRO) that provides integrated preclinical, regulatory, and clinical trial services. By leveraging unique tumor models, deep oncology insights, and accelerated regulatory pathways, TD2 assists biotech sponsors in rapidly moving promising cancer therapies from the bench to clinical proof-of-concept.